Arkolith/Insider Trading/RPHM/Form 4

Leonard Braden Michael

10% OwnerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Sep 26, 2024
Net Buying
Open-Market Buys
$145K
Open-Market Sells
$0
Net Open-Market Flow
$145K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2024Buy(P)69K$1.50$103K3.5M
Sep 24, 2024Buy(P)30K$1.41$42K3.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001373604-24-000098) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML